Shares of Catalyst Pharmaceuticals dropped 3.13% to $3.56 at 14:42 EST on Friday, following last session’s downward trend. NASDAQ Composite is dropping 0% to $13,530.25, after three consecutive sessions in a row of gains. This seems, at the moment, a somewhat positive trend trading session today.

Catalyst Pharmaceuticals’s last close was $3.67, 48.52% below its 52-week high of $5.28.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 0.8% for the current quarter and 5.5% for the next. The company’s growth estimates for the present quarter is 12.5% and a drop 20% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.

Volatility

Catalyst Pharmaceuticals’s last day, last week, and last month’s average volatility was a negative 0.54%, a positive 0.85%, and a positive 0.13%, respectively.

Catalyst Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 3.57%, 4.26%, and 4.24%, respectively.

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $3.56 at 14:42 EST, way under its 52-week high of $5.28 and way higher than its 52-week low of $2.55.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s worth is higher than its 50-day moving average of $3.55 and below its 200-day moving average of $3.61.

LEAVE A REPLY

Please enter your comment!
Please enter your name here